41
KUHAJDA Frank, RONNETT Gabrielle, TOWNSEND Craig: PROCÉDÉS DE CRIBLAGE DE COMPOSÉS QUI SONT CYTOTOXIQUES POUR DES CELLULES TUMORALES ET PROCÉDÉS DE TRAITEMENT DE CELLULES TUMORALES UTILISANT UN TEL COMPOSÉ, METHODS OF SCREENING COMPOUNDS THAT ARE CYTOTOXIC TO TUMOR CELLS AND METHODS OF TREATING TUMOR CELLS USING SUCH COMPOUND. RONNETT Gabrielle, TOWNSEND Craig, POSORSKE Laurence H, May 31, 2012: WO/2012/071562

Methods of screening for compounds that inhibit mammalian mitochondrial fatty acid synthase (mmF AS) and methods of treating tumor cells using mmF AS inhibitors, including methods for inhibiting or preventing cancer cell survival by administering inhibitors of mitochondrial fatty acid synthase (FAS) ...


42
STREEPER Robert T, IZBICKA Elzbieta, MICHALEK Joel, LOUDEN Chris: PROCÉDÉS DIDENTIFICATION ET DE DIAGNOSTIC DE MALADIES PULMONAIRES À LAIDE DE SYSTÈMES DE CLASSIFICATION ET LEURS KITS, METHODS OF IDENTIFICATION AND DIAGNOSIS OF LUNG DISEASES USING CLASSIFICATION SYSTEMS AND KITS THEREOF. CANCER PREVENTION AND CURE, STREEPER Robert T, IZBICKA Elzbieta, MICHALEK Joel, LOUDEN Chris, POSORSKE Laurence H, November 1, 2012: WO/2012/149550

The invention provides biomarkers and combinations of biomarkers useful in diagnosing lung diseases such as non-smail cell lung cancer or reactive airway disease. Measurements of these biomarkers are inputted into a classification system such as a support vector machine or AdaBoost to assist in dete ...


43
SRINIVASAN VENKATESH: Production of alkaloids by liliaceae cell culture. PHYTON HOLDINGS, Posorske Laurence H, December 23, 2010: WO/2010/148338

The invention relates to the production of alkaloids from Liliaceae cell culture.


44
Foster Alan Stimson, Koestner Mitchell Wayne, Kubovich Mark William, Meyer Trevor E: Electronic control system for a vacuum system. Electrolux Home Care Products, Foster Alan Stimson, Koestner Mitchell Wayne, Kubovich Mark William, Meyer Trevor E, POSORSKE Laurence H, December 21, 2007: WO/2007/146218

A programmable control unit for a vacuum cleaning system, such as central vacuum cleaning system. A control unit (300) is programmed after manufacture to execute a particular control program for performing various diagnostic and operational functions including user interface (150), voltage level det ...


45
Cherukuri Subraman Rao: Orally disintegrating layered compositions. Capricorn Pharma, Cherukuri Subraman Rao, POSORSKE Laurence H, January 3, 2008: WO/2008/002529

The present invention is directed to multi-layered compositions for oral administration having at least one orally disintegrating layer and capable of maintaining layer cohesion. The present invention is also directed to methods of manufacturing such compositions.


46
Sulakvelidze Alexander, Pasternack Gary: Novel pseudomonas aeruginosa: bacteriophage and uses thereof. Intralytix, Sulakvelidze Alexander, Pasternack Gary, POSORSKE Laurence H, December 24, 2008: WO/2008/157596

The present invention is directed to isolated bacteriophage having strong lytic activity against strains of Pseudomonas aeruginosa, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of Pseudomonas aeruginosa in various settings.


47
LEBEDEVA IRINA V: Profiling reactive oxygen, nitrogen and halogen species. ENZO LIFE SCIENCES, Posorske Laurence H, April 1, 2010: WO/2010/036922

This invention provides methods, kits and systems which permit simultaneous profiling of multiple reactive oxygen species (ROS), reactive nitrogen species (RNS) and/or reactive halogen species (RHS) including reactive chlorine species (RCS) and/or reactive bromine species (RBS) through multiplexed f ...


48
PASTERNACK GARY: Novel staphylococcus aureus: bacteriophage and uses thereof. INTRALYTIX, Posorske Laurence H, March 25, 2010: WO/2010/033546

The present invention is directed to isolated bacteriophage having strong lytic activity against strains of Staphylococcus aureus, in particular, MRSA, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of Staphylococcus aureus in various ...


49
Sulakvelidze Alexander, Pasternack Gary: Novel e. coli 0157:h7 bacteriophage and uses thereof. Intralytix, Sulakvelidze Alexander, Pasternack Gary, POSORSKE Laurence H, February 26, 2009: WO/2009/025906

The present invention is directed to isolated bacteriophage having strong lytic activity against strains of E. coli O157:H7, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of E. coli O157:H7 in various settings.


50
Pasternack Gary, Sulakvelidze Alexander: Novel clostridium perfringens bacteriophage and uses thereof. Intralytix, Pasternack Gary, Sulakvelidze Alexander, POSORSKE Laurence H, February 26, 2009: WO/2009/026219

The present invention is directed to isolated bacteriophage having strong lytic activity against strains of Clostridium perfringens, and methods of using that bacteriophage, and/or progeny or derivatives derived therefrom, to control the growth of Clostridium perfringens in various settings.